SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 10, 2004
COVALENT GROUP, INC.
(Exact name of issuer as specified in charter)
| | | | |
DELAWARE (State or Other Jurisdiction of Incorporation or Organization) | | 0-21145 (Commission file number) | | 56-1668867 (I.R.S. Employer Identification Number) |
One Glenhardie Corporate Center
1275 Drummers Lane
Suite 100
Wayne, Pennsylvania 19087
(Address of principal executive offices)
(610) 975-9533
(Registrant’s telephone number, including area code)
| Item 7. | Financial Statements, Pro Forma Financial Information and Exhibits. |
| | |
Exhibit No.
| | Description
|
| |
| 99.1 | | Covalent Group, Inc. Press Release dated March 10, 2004 |
| Item 12. | Results of Operations and Financial Condition. |
On March 10, 2004, Covalent Group, Inc. issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2003. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
The information in this report shall not be treated as “filed” for purposes of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Signatures
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | | | | | | | |
| | | | | COVALENT GROUP, INC. |
| | | |
Date: March 11, 2004 | | | | By: | | /s/ Kenneth M. Borow, M.D. |
| | | | | | | |
|
| | | | | | | Kenneth M. Borow, M.D. President and Chief Executive Officer |
Index to Exhibits
| | |
Exhibit No.
| | Description
|
| |
| 99.1 | | Covalent Group, Inc. Press Release dated March 10, 2004 |
